Avsar.

Consumer Discretionary · Pharmacy Retail

Medplus Health Services Ltd (MEDPLUS)

₹579.90

Mkt cap
₹6,968 Cr
P/E ratio
33.00
P/B
3.37
Div yield
0.00%
ROE
11.60%
ROCE
12.60%
EPS (TTM)
₹17.57
Book value
₹172
52W range
566–1,022
Sector
Consumer Discretionary

Price history

Previous close

Medplus Health · Mkt Cap: 6,968 Crore (down -24.0% in 1 year) · Revenue: 7,587 Cr · Profit: 211 Cr · Stock is trading at 3.37 times its book value · Though the company is reporting repeated profits, it is not paying out dividend · Promoter Holding: 40.2%

NSE MEDPLUSBSE 543427
Health check
Constructive
ValuationCheap
ProfitabilityAverage
GrowthHigh
TechnicalsBearish
52-week range
−43.27% from high
₹580
₹566+2.53% from low₹1,022
Current
₹579.90
Prev close
₹598.05
Day
−3.03%
Price performance
1D
−3.85%
1W
−3.39%
1M
−12.08%
3M
−19.55%
6M
−34.70%
1Y
−23.81%
YTD
−28.25%

Financials

Revenue, profit & margin
P/E ratio
33.0×
MEDPLUS is 23% below the sector median of 43.1×
MEDPLUS33.0×
Sector median43.1×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales1,4091,4411,4901,4891,5761,5611,5101,5431,6791,8061,8641,8802,037
Expenses1,3241,3501,3851,3951,4521,4291,3731,4121,5301,6481,6951,7461,867
Operating Profit859210694124133136131149159169133170
OPM %6%6%7%6%8%8%9%8%9%9%9%7%8%
Other Income1010109121316151718212021
Interest24242525252627272931333337
Depreciation55575960636264666973767884
Profit before tax16203218485761536973804270
Tax %12%31%-5%19%19%19%16%20%19%21%20%21%20%
Net Profit15143414394651425658643356
EPS in Rs1.221.152.791.203.243.834.293.544.634.825.332.764.67
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −1.94% · closed higher next day 0 of last 1
 Q2FY27
Broadcast27 Oct '26◦
Earnings day−1.94%
+1 day−3.77%
+5 days—
+15 days—
+30 days—
FilingXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Results analysis

Shareholding

as of Sep 2026
40.20%Promoter
Promoters40.20%0.01
FIIs12.58%1.80
DIIs31.89%1.94
Public15.31%0.14
Ownership trend

Peers

2 companies
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Medplus Health₹579.9033.026,9680.00%56+1.05%2,037+21.30%12.56%
Entero Healthcar₹1,575.2053.186,8630.00%52+37.27%1,941+38.23%10.47%
Median: 2 Co.₹1,077.5543.106,9150.00%54+19.16%1,989+29.77%11.52%

Filings

Annual reports6
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022Annual Report 2022
Concall transcripts48
PPTOct 2026RECOct 2026TranscriptJul 2026PPTJul 2026RECJul 2026PPTJul 2026TranscriptMay 2026PPTMay 2026RECMay 2026TranscriptFeb 2026PPTFeb 2026RECFeb 2026TranscriptNov 2025PPTNov 2025TranscriptAug 2025PPTAug 2025RECAug 2025TranscriptMay 2025PPTMay 2025RECMay 2025TranscriptFeb 2025PPTFeb 2025TranscriptNov 2024PPTNov 2024
Announcements5
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011. 31 OctDisclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011. 31 Oct - Lone Furrow Investments pledged 18,00,000 Medplus shares on October 23, 2026; total pledged shares rose to 88,00,000.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 31 Oct - Promoter Agilemed created pledge over 9.75 lakh shares on October 23, 2026; no fresh borrowing.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 31 OctClosure of Trading Window 30 Oct - Board meeting on November 6, 2026 to consider buyback of fully paid-up equity shares.